Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)
NCT04750629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2021-06-18
Summary
Prospective study that will evaluate the clinical agreement of the CoviDx™ Rapid Antigen test compared to SARS-CoV-2 RT-PCR.
Conditions
- SARS-CoV-2
- Covid19
Interventions
- DEVICE
-
POC CoviDx™ Rapid Antigen Test
All patients will have a nasal swab for CoviDx™ Rapid Antigen testing
Sponsors & Collaborators
-
Rapid Pathogen Screening
collaborator INDUSTRY -
Lumos Diagnostics
lead INDUSTRY
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-08
- Primary Completion
- 2021-05-07
- Completion
- 2021-05-14
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19
NCT04405492 ·Status: UNKNOWN ·Phase: NA
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
NCT06744660 ·Status: RECRUITING ·Phase: NA
-
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
NCT05584189 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Point-of-Care (EPOC) for COVID-19
NCT05227404 ·Status: COMPLETED
-
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
NCT04667442 ·Status: COMPLETED
-
Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19
NCT04662671 ·Status: COMPLETED ·Phase: NA
-
TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood
NCT05338762 ·Status: COMPLETED
-
Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept
NCT04780334 ·Status: COMPLETED
-
Saliva-based COVID-19 DNA Aptamer Test
NCT04974203 ·Status: UNKNOWN ·Phase: NA
-
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
NCT06402318 ·Status: RECRUITING
-
BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test
NCT04959760 ·Status: COMPLETED ·Phase: NA
-
A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device
NCT04357977 ·Status: UNKNOWN
-
Wearable Diagnostic for Detection of COVID-19 Infection
NCT04742569 ·Status: COMPLETED
-
CareSuperb COVID-19 Antigen Test Usability
NCT05629455 ·Status: COMPLETED ·Phase: NA
-
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
NCT04368897 ·Status: WITHDRAWN
-
GlowTest COVID-19 Antigen Home Test Kit QRI Use Study
NCT05140005 ·Status: COMPLETED ·Phase: NA
-
The Nanowear Wearable Covid-19 Observational and Analysis Trend
NCT04717024 ·Status: TERMINATED
-
GlowTest COVID-19 Antigen Home Test Kit Usability Study
NCT05172154 ·Status: COMPLETED
-
EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO)
NCT05618561 ·Status: TERMINATED
-
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
NCT00520273 ·Status: COMPLETED ·Phase: NA
-
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
NCT05196932 ·Status: COMPLETED
-
Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System
NCT04311398 ·Status: UNKNOWN
-
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
NCT04393961 ·Status: UNKNOWN ·Phase: NA
-
Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test
NCT05771714 ·Status: TERMINATED ·Phase: NA